HALO logo
halo search icon
Equillium, Inc.

US$2.06

Price Change Indicator
0.30 (16.71%)
Equillium, Inc.
EQ · NAS

Equillium, Inc.

Start Trading EQ for Free

US$2.06

Price Arrow0.30 (16.71%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleBig Candle (Realtime)HALO AllHALO Consensus ValueHALO MomentumHALO Price Momentum+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Equillium, Inc. Overview

EQ Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About EQ

icon
icon

Telephone

1.858.240.1200

icon

Address

Suite 105, 2223 Avenida de la Playa, La Jolla, CA 92037

Description

Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March 2017 and is headquartered in La Jolla, CA.

EQ Price Chart

Key Stats

Market Cap

US$111.59M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.27 - 2.7

Trade Value (12mth)

US$622,345.00

1 week

-19.04%

1 month

-17.91%

YTD

15.36%

1 year

358.32%

All time high

27.05

Key Fundamentals

EPS 3 yr Growth

-78.90%

EBITDA Margin

0.00%

Operating Cashflow

-$23m

Free Cash Flow Return

-94.40%

ROIC

-92.90%

Interest Coverage

0.00

Quick Ratio

10.60

Other Data

Shares Outstanding (Fully Diluted)

96m

HALO Sector

Healthcare

Next Company Report Date

24-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

EQ Announcements

Latest Announcements

DateAnnouncements
20 May 26
14 May 26
14 May 26
14 May 26
14 May 26

EQ Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.38-0.23-0.39locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.38-0.23-0.39locklocklock
Growth
 %locklocklocklock79.340.6-71.3locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Equillium, Inc. (EQ:NAS)?
Halo FAQ
The current share price of Equillium, Inc. (EQ:NAS) is USD$2.06.
What is the 52-week high share price for Equillium, Inc. (EQ:NAS)?
Halo FAQ
The 52-week high share price for Equillium, Inc. (EQ:NAS) is USD$2.70.
What is the 52-week low share price for Equillium, Inc. (EQ:NAS)?
Halo FAQ
The 52-week low share price for Equillium, Inc. (EQ:NAS) is USD$0.27.
What is the dividend yield for Equillium, Inc. (EQ:NAS)?
Halo FAQ
Equillium, Inc. (EQ:NAS) does not pay a dividend.
What was Equillium, Inc. (EQ:NAS) last dividend payment?
Halo FAQ
Equillium, Inc. (EQ:NAS) does not pay a dividend.
What is the franking level for Equillium, Inc. (EQ:NAS)?
Halo FAQ
Equillium, Inc. (EQ:NAS) has a franking level of 0.00%.
In which sector is Equillium, Inc. (EQ:NAS) classified?
Halo FAQ
Equillium, Inc. (EQ:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial